clarithromycin has been researched along with Long QT Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bies Pivackova, L; Doka, G; Hadova, K; Klimas, J; Kmecova, J; Kralova, E; Krenek, P; Ochodnicka-Mackovicova, K; Stankovicova, T; Vavrinec, P | 1 |
| Grindrod, KA; Nagge, J | 1 |
| Baranchuk, A; Gysel, M; Hancox, JC; Hasnain, M; Kunanithy, V; Vieweg, WV | 1 |
| Bienias, P; Ciurzyński, M; Paczyńska, M; Pruszczyk, P | 1 |
| Andersen, SE; Buch, T | 1 |
| Ribera, E; Rodríguez Pardo, D; Sánchez Hidalgo, A; Soler Soler, J; Tornos Mas, MP; Vallejo Camazón, N | 1 |
| Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N | 1 |
| Amano, M; Arai, M; Hasegawa, A; Kaneko, Y; Kurabayashi, M; Nakamura, T; Ohyama, Y; Yamagishi, T; Yamaguchi, S | 1 |
| Andreu Rodríguez, AL; Bertomeu Martínez, V; Díaz García, MJ; Morillas Blasco, P | 1 |
| Galanakis, E; Germanakis, I; Kalmanti, M; Parthenakis, F; Vardas, PE | 1 |
| Gray, VS | 1 |
| Koci, BJ; Lin, J; Su, W; Volberg, WA; Zhou, J | 1 |
1 review(s) available for clarithromycin and Long QT Syndrome
| Article | Year |
|---|---|
Simplifying QT prolongation for busy clinicians.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Family Practice; Female; Humans; Long QT Syndrome; Male; Pneumonia; Risk Assessment; Risk Factors; Torsades de Pointes | 2019 |
1 trial(s) available for clarithromycin and Long QT Syndrome
| Article | Year |
|---|---|
Clarithromycin treatment and QT prolongation in childhood.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Electrocardiography; Female; Humans; Infant; Long QT Syndrome; Male; Respiratory Tract Infections | 2006 |
10 other study(ies) available for clarithromycin and Long QT Syndrome
| Article | Year |
|---|---|
Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation.
Topics: Adrenergic Agents; Animals; Arrhythmias, Cardiac; Calcium Channels; Clarithromycin; DNA-Binding Proteins; Furosemide; Long QT Syndrome; Pharmaceutical Preparations; Rats; RNA, Messenger | 2023 |
Torsades de pointes following clarithromycin treatment.
Topics: Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Electric Countershock; Female; Heart Arrest; Humans; Long QT Syndrome; Risk Factors; Sex Factors; Torsades de Pointes | 2013 |
Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clarithromycin; Drug Therapy, Combination; Electrocardiography; Heart Arrest; Humans; Long QT Syndrome; Male; Middle Aged; Pneumonia; Pulmonary Edema; Torsades de Pointes; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
[Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Combined Modality Therapy; Drug Interactions; Electrocardiography; Fluconazole; Heart Rate; Humans; Long QT Syndrome; Male | 2015 |
[Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Electrocardiography; Follow-Up Studies; HIV Infections; Humans; Long QT Syndrome; Male; Tachycardia, Ventricular; Time Factors | 2002 |
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes | 2002 |
[Clarithromycin-induced torsades de pointes].
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Long QT Syndrome; Torsades de Pointes | 2003 |
[EKG changes in a patient with respiratory infection].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Electrocardiography; Humans; Long QT Syndrome; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections | 2005 |
Syncopal episodes associated with cisapride and concurrent drugs.
Topics: Accidents, Traffic; Anti-Bacterial Agents; Anti-Ulcer Agents; Cisapride; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Interactions; Electrocardiography; Female; Gastrointestinal Agents; Humans; Long QT Syndrome; Middle Aged; Omeprazole; Piperidines; Syncope | 1998 |
Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics.
Topics: Anti-Bacterial Agents; Cation Transport Proteins; Cell Line; Clarithromycin; DNA-Binding Proteins; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Kinetics; Long QT Syndrome; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Trans-Activators; Transcriptional Regulator ERG | 2002 |